Natural Product: NPC478065

Natural Product IDNPC478065
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
butyl (2S,3S,4S,5R,6R)-6-[[(3S,6aR,6bS,7R,8S,8aR,9S,12aS,14aR,14bR)-9-[(2E)-3,7-dimethylocta-2,6-dienoyl]oxy-7,8-dihydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylate
IUPAC Name butyl (2S,3S,4S,5R,6R)-6-[[(3S,6aR,6bS,7R,8S,8aR,9S,12aS,14aR,14bR)-9-[(2E)-3,7-dimethylocta-2,6-dienoyl]oxy-7,8-dihydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 44575724
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001580] Triterpene glycosides
            • [CHEMONTID:0002358] Triterpene saponins

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey KEDJBUGHODJQAX-JCHISVDESA-N
Standard InCHI InChI=1S/C61H98O21/c1-12-13-23-75-52(74)49-47(80-53-44(69)42(67)35(28-63)77-53)46(71)48(81-54-45(70)43(68)41(66)34(27-62)76-54)55(82-49)79-38-20-21-58(9)36(57(38,7)8)19-22-59(10)37(58)18-17-32-33-25-56(5,6)26-39(61(33,29-64)51(73)50(72)60(32,59)11)78-40(65)24-31(4)16-14-15-30(2)3/h15,17,24,33-39,41-51,53-55,62-64,66-73H,12-14,16,18-23,25-29H2,1-11H3/b31-24+/t33-,34+,35-,36?,37+,38-,39-,41+,42-,43-,44+,45+,46-,47-,48+,49-,50-,51+,53-,54-,55+,58-,59+,60-,61+/m0/s1
SMILES CCCCOC(=O)[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC=C5[C@@H]6CC(C[C@@H]([C@@]6([C@@H]([C@@H]([C@]5([C@@]4(CCC3C2(C)C)C)C)O)O)CO)OC(=O)/C=C(\C)/CCC=C(C)C)(C)C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H](O8)CO)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1166.66 Volume:   1166.572
?
Van der Waals volume.
Dense:   1.0 LogP:   4.254
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.365
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.924
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   20.0 Rigid Bonds:   47.0
TPSA:   330.51
?
Topological Polar Surface Area.
H-Bond Acceptor:   21.0
H-Bond Donor:   11.0 Rings:   8.0
Heavy Atoms:   21.0

MedChem Properties

QED Drug-Likeness Score:   0.031 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.031 Fsp3:   0.869
MCE-18:   176.561
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.953 Fluc inhibitor:   0.002
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.002
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.003
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.193 Promiscuous compounds:   0.307

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.393 MDCK Permeability:   -5.145
Pgp-inhibitor:   0.0 Pgp-substrate:   0.005
PAMPA:   0.914
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.461 30% Bioavailability (F30%):   0.922
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.226 MRP1:   0.449
Plasma Protein Binding (PPB):   85.439% Volume Distribution (VD):   -0.333
Fu: 8.094%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.0
BSEP inhibitor:   0.338

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.113 CYP2C19-substrate:   0.033
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.001
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.952
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.995
HLM stability:   1.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.118 Half-life (T1/2):  2.977

ADMET: Toxicity

hERG Blockers:  0.004 hERG Blockers (10um):  0.021
Human Hepatotoxicity (H-HT):  0.379 Drug-induced Liver Injury (DILI):  0.961
AMES Toxicity:  0.814 Rat Oral Acute Toxicity:  0.006
Maximum Recommended Daily Dose:  0.003 Skin Sensitization:  1.0
Carcinogencity:  0.077 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.007
Drug-induced Neurotoxicity:  0.002 Ototoxicity:  0.998
Hematotoxicity:  0.762 Drug-induced Nephrotoxicity:  0.998
Genotoxicity:  0.079 RPMI-8226 Immunitoxicity:  0.424
A549 Cytotoxicity:  0.971 Hek293 Cytotoxicity:  0.732
BCF:   1.402
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.174
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.966
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.019
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8121 Symplocos chinensis Species Symplocaceae Eukaryota roots n.a. n.a. PMID[15620235]
NPO8121 Symplocos chinensis Species Symplocaceae Eukaryota roots Nanning City, Guangxi Province, People's Republic of China 1997-Jan PMID[17190442]
NPO8121 Symplocos chinensis Species Symplocaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8121 Symplocos chinensis Species Symplocaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8121 Symplocos chinensis Species Symplocaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT180 Cell line HCT-8 Homo sapiens IC50 = 4.04 ug/ml PMID[15620235]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC478065 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC301639
0.8448 Intermediate Similarity NPC173435
0.8448 Intermediate Similarity NPC172374
0.8448 Intermediate Similarity NPC478064
0.7881 Intermediate Similarity NPC329993
0.7563 Intermediate Similarity NPC134914
0.6977 Remote Similarity NPC69425
0.6885 Remote Similarity NPC264566
0.6667 Remote Similarity NPC478066
0.6378 Remote Similarity NPC475167
0.6311 Remote Similarity NPC609281
0.6016 Remote Similarity NPC477075
0.6 Remote Similarity NPC329923
0.6 Remote Similarity NPC475281
0.6 Remote Similarity NPC295408
0.5985 Remote Similarity NPC225791
0.5985 Remote Similarity NPC262796
0.5985 Remote Similarity NPC45346
0.5935 Remote Similarity NPC470914
0.5896 Remote Similarity NPC475377
0.5896 Remote Similarity NPC476074
0.5865 Remote Similarity NPC475513
0.5802 Remote Similarity NPC470912
0.5748 Remote Similarity NPC606553
0.5691 Remote Similarity NPC235438
0.5682 Remote Similarity NPC277212
0.5682 Remote Similarity NPC30279
0.5645 Remote Similarity NPC470913
0.5639 Remote Similarity NPC71391
0.5636 Remote Similarity NPC474190
0.5564 Remote Similarity NPC473918
0.5563 Remote Similarity NPC150893
0.5538 Remote Similarity NPC610461
0.552 Remote Similarity NPC222580
0.5469 Remote Similarity NPC80986
0.5426 Remote Similarity NPC329976
0.542 Remote Similarity NPC610204
0.5391 Remote Similarity NPC606145
0.5349 Remote Similarity NPC477078
0.5319 Remote Similarity NPC484063
0.5319 Remote Similarity NPC484064
0.5303 Remote Similarity NPC607904
0.5267 Remote Similarity NPC62725
0.5252 Remote Similarity NPC484833
0.5191 Remote Similarity NPC31838
0.5185 Remote Similarity NPC609305
0.5161 Remote Similarity NPC39211
0.5149 Remote Similarity NPC1314
0.5149 Remote Similarity NPC273878
0.5145 Remote Similarity NPC178264
0.5145 Remote Similarity NPC473755
0.5109 Remote Similarity NPC46823
0.5072 Remote Similarity NPC192765
0.504 Remote Similarity NPC603026
0.5038 Remote Similarity NPC605294
0.5035 Remote Similarity NPC484059
0.5035 Remote Similarity NPC484060

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478065 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data